[go: up one dir, main page]

EP1711490A4 - Inhibiteur de p-glycoproteine, procede de preparation, et composition pharmaceutique le renfermant - Google Patents

Inhibiteur de p-glycoproteine, procede de preparation, et composition pharmaceutique le renfermant

Info

Publication number
EP1711490A4
EP1711490A4 EP04774781A EP04774781A EP1711490A4 EP 1711490 A4 EP1711490 A4 EP 1711490A4 EP 04774781 A EP04774781 A EP 04774781A EP 04774781 A EP04774781 A EP 04774781A EP 1711490 A4 EP1711490 A4 EP 1711490A4
Authority
EP
European Patent Office
Prior art keywords
preparation
same
pharmaceutical composition
glycoprotein inhibitor
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04774781A
Other languages
German (de)
English (en)
Other versions
EP1711490A1 (fr
Inventor
Mi Young Cha
Keuk Chan Bang
Young Gil Ahn
Maeng Sup Kim
Gwan Sun Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Publication of EP1711490A1 publication Critical patent/EP1711490A1/fr
Publication of EP1711490A4 publication Critical patent/EP1711490A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP04774781A 2003-10-08 2004-10-07 Inhibiteur de p-glycoproteine, procede de preparation, et composition pharmaceutique le renfermant Withdrawn EP1711490A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020030069803A KR100580743B1 (ko) 2003-10-08 2003-10-08 다약제 내성 저해 활성을 갖는 신규한 크로몬 유도체 또는이의 약제학적으로 허용가능한 염 및 이들의 제조 방법
PCT/KR2004/002557 WO2005033101A1 (fr) 2003-10-08 2004-10-07 Inhibiteur de p-glycoproteine, procede de preparation, et composition pharmaceutique le renfermant

Publications (2)

Publication Number Publication Date
EP1711490A1 EP1711490A1 (fr) 2006-10-18
EP1711490A4 true EP1711490A4 (fr) 2007-04-04

Family

ID=36968286

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04774781A Withdrawn EP1711490A4 (fr) 2003-10-08 2004-10-07 Inhibiteur de p-glycoproteine, procede de preparation, et composition pharmaceutique le renfermant

Country Status (3)

Country Link
EP (1) EP1711490A4 (fr)
KR (1) KR100580743B1 (fr)
WO (1) WO2005033101A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100557093B1 (ko) 2003-10-07 2006-03-03 한미약품 주식회사 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법
KR100724125B1 (ko) * 2005-02-24 2007-06-04 한국과학기술연구원 칼페인 저해제로 유용한 크로몬 유도체 및 이의 제조방법
KR100880163B1 (ko) * 2007-05-30 2009-02-04 (주)바이오버드 신규한 다약제 내성 억제 화합물 및 이를 포함하는약제학적 조성물
CN111629716A (zh) 2017-07-14 2020-09-04 马萨诸塞大学 治疗炎症的方法和组合物
EP4438618A3 (fr) 2018-08-22 2025-01-01 Bacainn Biotherapeutics, Ltd. Compositions de cyclosporine et méthodes d'utilisation
CN113631166A (zh) * 2018-12-14 2021-11-09 慧源香港创新有限公司 用于治疗癌症的口服给药的伊立替康和P-gp抑制剂的治疗组合
CN111732567B (zh) * 2020-06-17 2022-07-08 遵义医科大学 一种含色酮骨架类多环化合物、制备方法及其应用
WO2022076662A1 (fr) * 2020-10-07 2022-04-14 Athenex, Inc. Dérivés acétamido-phénylbenzamides et leurs procédés d'utilisation
CN117603219B (zh) * 2023-11-29 2025-08-08 浙江大学 一种p-糖蛋白抑制剂及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011069A (en) * 1995-12-26 2000-01-04 Nisshin Flour Milling Co., Ltd. Multidrug resistance inhibitors
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
KR100503161B1 (ko) * 2002-07-18 2005-07-25 한미약품 주식회사 신규한 ｐ-당단백질 저해제, 그의 제조방법 및 이를유효성분으로 하는 경구투여용 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
KR20050034024A (ko) 2005-04-14
WO2005033101A1 (fr) 2005-04-14
EP1711490A1 (fr) 2006-10-18
KR100580743B1 (ko) 2006-05-15

Similar Documents

Publication Publication Date Title
EP1425019A4 (fr) Composition pharmaceutique
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
FI20011478L (fi) Farmaseuttinen koostumus
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
RS20120139A3 (en) 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
DK1575618T3 (da) Dispergerbare farmaceutiske kombinationer
PT102854B (pt) Sistema de aplicacao de medicamento bioadesivo
DE60229819D1 (de) Antriebsstrang und dessen Zusammenbaumethode
PL378135A1 (pl) 2-Cyjanopirolopirymidyny i ich zastosowania w farmaceutykach
IL197159A0 (en) Rna molecules and pharmaceutical compositions containing the same
EE200300416A (et) Ravimvorm
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK1587478T3 (da) Farmaceutisk sammensætning
EP1562618A4 (fr) Compositions de withanolides inhibant la cyclooxygenase-2 et methode associee
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
FI20022128L (fi) Farmaseuttinen koostumus
IL174479A (en) The derivatives of myastrin, pharmaceutical preparations containing them and their uses
EP1711490A4 (fr) Inhibiteur de p-glycoproteine, procede de preparation, et composition pharmaceutique le renfermant
PT1590314E (pt) Ácidos 2-aril-acéticos, seus derivados e composições farmacêuticas que os contêm
FI20031703A7 (fi) Jarru ja menetelmä jarrun säätämiseksi
EP1581258A4 (fr) Formulation pharmaceutique et procede de realisation associe
FI20031065A0 (fi) Hyönteissuoja-aine, menetelmä sen valmistamiseksi ja sen käyttö
FI20030627A0 (fi) Menetelmä ja järjestely kaasunpoistossa, sekä niiden käyttö

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060814

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070301

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1093204

Country of ref document: HK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100212

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1093204

Country of ref document: HK